These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23167862)

  • 1. Contrast-induced nephropathy: doubts and certainties.
    Mitchell AM; Kline JA
    Acad Emerg Med; 2012 Nov; 19(11):1294-6. PubMed ID: 23167862
    [No Abstract]   [Full Text] [Related]  

  • 2. The changing definition of contrast-induced nephropathy and its clinical implications: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Slocum NK; Grossman PM; Moscucci M; Smith DE; Aronow HD; Dixon SR; Share D; Gurm HS
    Am Heart J; 2012 May; 163(5):829-34. PubMed ID: 22607861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the current definition of contrast-induced acute kidney injury reflect a true clinical entity?
    Sinert R; Brandler E; Subramanian RA; Miller AC
    Acad Emerg Med; 2012 Nov; 19(11):1261-7. PubMed ID: 23167857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Katzberg RW; Newhouse JH
    Radiology; 2010 Jul; 256(1):21-8. PubMed ID: 20574082
    [No Abstract]   [Full Text] [Related]  

  • 5. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for contrast-related acute kidney injury according to risk, injury, failure, loss, and end-stage criteria in patients with coronary interventions.
    Pakfetrat M; Nikoo MH; Malekmakan L; Tabande M; Roozbeh J; Reisjalali G; Zare N; Khajedehi P
    Iran J Kidney Dis; 2010 Apr; 4(2):116-22. PubMed ID: 20404421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in risk assessment for development of contrast-induced acute kidney injury using the MDRD versus CKD-EPI equations to estimate glomerular filtration rate.
    Rootjes PA; Bax WA; Penne EL
    Eur J Intern Med; 2016 Dec; 36():e33-e34. PubMed ID: 27616270
    [No Abstract]   [Full Text] [Related]  

  • 8. Subclinical acute kidney injury (AKI) due to iodine-based contrast media.
    Ronco C; Stacul F; McCullough PA
    Eur Radiol; 2013 Feb; 23(2):319-23. PubMed ID: 22895617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dialysis in contrast-induced nephropathy: doubts and certainties.
    Guastoni C; De Servi S; D'Amico M
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):549-57. PubMed ID: 17667024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced acute kidney injury: time for a step backward.
    Sinert R; Brandler E
    Acad Emerg Med; 2014 Jun; 21(6):701-3. PubMed ID: 25039557
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Nomura S; Taki F; Tamagaki K; Futatsuyama M; Nishihara S; Anzai H; Nishi Y; Takao N; Hayashida N; Komatsu Y
    Int J Cardiol; 2011 Jan; 146(2):295-6. PubMed ID: 21095626
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials.
    Dai B; Liu Y; Fu L; Li Y; Zhang J; Mei C
    Am J Kidney Dis; 2012 Sep; 60(3):360-70. PubMed ID: 22516682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.
    Briguori C; Visconti G; Focaccio A; Airoldi F; Valgimigli M; Sangiorgi GM; Golia B; Ricciardelli B; Condorelli G;
    Circulation; 2011 Sep; 124(11):1260-9. PubMed ID: 21844075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quiz page June 2012: kidney failure in an HIV-positive patient.
    Coelho S; Aparício SR; Manso R; Soto K
    Am J Kidney Dis; 2012 Jun; 59(6):A27-30. PubMed ID: 22613399
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radiological contrast and acute renal insufficiency].
    Ajzen SA; Schor N
    AMB Rev Assoc Med Bras; 1987; 33(9-10):175-6. PubMed ID: 3505723
    [No Abstract]   [Full Text] [Related]  

  • 17. Baseline creatinine to define acute kidney injury: is there any consensus?
    Gaião S; Cruz DN
    Nephrol Dial Transplant; 2010 Dec; 25(12):3812-4. PubMed ID: 20663790
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast-induced nephropathy in critical care.
    Wood SP
    Crit Care Nurse; 2012 Dec; 32(6):15-23; quiz 1p following page 23. PubMed ID: 23203951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat.
    Haylor J; Dencausse A; Vickers M; Nutter F; Jestin G; Slater D; Idee JM; Morcos S
    Invest Radiol; 2010 Sep; 45(9):507-12. PubMed ID: 20697223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
    Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
    Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.